Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanna Campo

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Nephrology|November 9, 2010
Erythropoietin and the truths of scienceMichele Buemi, Susanna Campo, Valeria Cernaro, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 8, 2023
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresisAntonio Lacquaniti, Susanna Campo, Alessandro Russo, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney DiseaseAntonio Lacquaniti, Fabrizio Ceresa, Susanna Campo, et al.
Journal of Clinical Medicine|July 9, 2022
Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same CoinSusanna Campo, Antonio Lacquaniti, Domenico Trombetta, et al.
Renal Failure|May 15, 2007
Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect?Alessio Sturiale, Susanna Campo, Eleonora Crascì, et al.
The Journal of Obstetrics and Gynaecology Research|April 17, 2008
Pregnancy in uremic patients: an eventful journeyDavide Bolignano, Giuseppe Coppolino, Eleonora Crascì, et al.
Kidney & Blood Pressure Research|July 5, 2008
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney diseaseDavide Bolignano, Antonio Lacquaniti, Giuseppe Coppolino, et al.
Current Pharmaceutical Design|April 14, 2007
Aquaretic agents: what's beyond the treatment of hyponatremia?Davide Bolignano, Giuseppe Coppolino, Manila Criseo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 18, 2008
Circulating progenitor cells after cold pressor test in hypertensive and uremic patientsGiuseppe Coppolino, Davide Bolignano, Susanna Campo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2008
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damageDavide Bolignano, Valentina Donato, Giuseppe Coppolino, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Nephrology|November 9, 2010
Erythropoietin and the truths of scienceMichele Buemi, Susanna Campo, Valeria Cernaro, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 8, 2023
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresisAntonio Lacquaniti, Susanna Campo, Alessandro Russo, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Left Ventricular Mass Index Predicts Renal Function Decline in Patients with Chronic Kidney DiseaseAntonio Lacquaniti, Fabrizio Ceresa, Susanna Campo, et al.
Journal of Clinical Medicine|July 9, 2022
Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same CoinSusanna Campo, Antonio Lacquaniti, Domenico Trombetta, et al.
Renal Failure|May 15, 2007
Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect?Alessio Sturiale, Susanna Campo, Eleonora Crascì, et al.
The Journal of Obstetrics and Gynaecology Research|April 17, 2008
Pregnancy in uremic patients: an eventful journeyDavide Bolignano, Giuseppe Coppolino, Eleonora Crascì, et al.
Kidney & Blood Pressure Research|July 5, 2008
Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney diseaseDavide Bolignano, Antonio Lacquaniti, Giuseppe Coppolino, et al.
Current Pharmaceutical Design|April 14, 2007
Aquaretic agents: what's beyond the treatment of hyponatremia?Davide Bolignano, Giuseppe Coppolino, Manila Criseo, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|July 18, 2008
Circulating progenitor cells after cold pressor test in hypertensive and uremic patientsGiuseppe Coppolino, Davide Bolignano, Susanna Campo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 30, 2008
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damageDavide Bolignano, Valentina Donato, Giuseppe Coppolino, et al.
Pageof 4